Adipose tissue dysfunction in humans: A potential role for the transmembrane protein ENPP1

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4663-4672

  Chandalia, Manisha ^a,b   Davila, Himara ^a   Pan, Wentong ^a   Szuszkiewicz, Magdalena ^b   Tuvdendorj, Demidmaa ^a   Livingston, Edward H ^b   Abate, Nicola ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CD11B ANTIGEN; CD36 ANTIGEN; CD68 ANTIGEN; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; FATTY ACID; GLUCOSE; HORMONE SENSITIVE LIPASE; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN LIPASE; MEMBRANE PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL SUBCUTANEOUS FAT; ACSL1 GENE; ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; CD36 GENE; CD68 GENE; FATTY ACID BLOOD LEVEL; FEMALE; GENE; GENE EXPRESSION; HSL GENE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN RESISTANCE; LIPID LIVER LEVEL; LPL GENE; MAC1 GENE; MALE; MUSCLE LEVEL; NEEDLE BIOPSY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SREBP1C GENE; UPREGULATION;

ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID METABOLISM DISORDERS; LIVER; MALE; MEMBRANE PROTEINS; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84870735641     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2018     Document Type: Article

References (34)

1. Bao W, Srinivasan SR, Berenson GS 1996 Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93:54-59 (Pubitemid 26006568)
2. DeFronzo RA, Ferrannini E 1991 Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
3. Abbasi F, Brown Jr BW, Lamendola C, McLaughlin T, Reaven GM 2002 Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40:937-943 (Pubitemid 34994988)
4. Reaven GM 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607 (Pubitemid 19004941)
5. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven GM 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706 (Pubitemid 19072489)
6. Bays H, Abate N, Chandalia M 2005 Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol 1:39-59
7. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S 1998 The metabolically obese, normal-weight individual revisited. Diabetes 47:699-713 (Pubitemid 28201798)
8. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM 1999 Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84:2329-2335
9. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR 2008 The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168:1617-1624
10. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU 2008 Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609-1616
11. Pan W, Ciociola E, Saraf M, Tumurbaatar B, Tuvdendorj D, Prasad S, Chandalia M, Abate N 2011 Metabolic consequences of ENPP1 overexpression in adipose tissue. Am J Physiol Endocrinol Metab 301:E901-E911
12. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L 2008 The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 29:62-75 (Pubitemid 351252747)
13. Maddux BA, Goldfine ID 2000 Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor α-subunit. Diabetes 49:13-19 (Pubitemid 30022918)
14. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, Goldfine ID, Trischitta V 1997 Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 40:282-289 (Pubitemid 27096551)
15. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM 1995 Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96:88-98
16. Abate N, Burns D, Peshock RM, Garg A, Grundy SM 1994 Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 35:1490-1496 (Pubitemid 24251044)
17. Vega GL, Chandalia M, Szczepaniak LS, Grundy SM 2008 Effects of N-3 fatty acids on hepatic triglyceride content in humans. J Investig Med 56:780-785
18. Vega GL, Chandalia M, Szczepaniak LS, Grundy SM 2007 Metabolic correlates of nonalcoholic fatty liver inwomenand men. Hepatology 46:716-722 (Pubitemid 47436117)
19. Boden G, Chen X, Desantis RA, Kendrick Z 1993 Effects of insulin on fatty acid reesterification in healthy subjects. Diabetes 42:1588-1593 (Pubitemid 23318114)
20. Jensen MD, Ekberg K, Landau BR 2001 Lipid metabolism during fasting. Am J Physiol Endocrinol Metab 281:E789-E793
21. Nye C, Kim J, Kalhan SC, Hanson RW 2008 Reassessing triglyceride synthesis in adipose tissue. Trends Endocrinol Metab 19:356-361
22. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK, Davis RJ 2009 Prevention of steatosis by hepatic JNK1. Cell Metab 10:491-498
23. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ 2008 A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539-1543
24. Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG 2012 The inflammasome puts obesity in the danger zone. Cell Metab 15:10-18
25. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD 2011 Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 108:15324-15329
26. Liang J, Fu M, Ciociola E, Chandalia M, Abate N 2007 Role of ENPP1 on adipocyte maturation. PLoS One 2:e882
27. Pisto P, Ukkola O, Santaniemi M, Kesäniemi YA 2011 Plasma adiponectin-an independent indicator of liver fat accumulation. Metabolism 60:1515-1520
28. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R, Kadowaki T 2009 Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun 382:51-56
29. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocr Rev 26:439-451 (Pubitemid 40686653)
30. Kadowaki T, Yamauchi T, Kubota N 2008 The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582:74-80 (Pubitemid 50012818)
31. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295 (Pubitemid 35373562)
32. Shetty S, Ramos-Roman MA, Cho YR, Brown J, Plutzky J, Muise ES, Horton JD, Scherer PE, Parks EJ 2012 Enhanced fatty acid flux triggered by adiponectin overexpression. Endocrinology 153:113-122
33. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446 (Pubitemid 24177157)
34. Homko CJ, Cheung P, Boden G 2003 Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 52:487-491 (Pubitemid 36173207)